Placental-Derived Biomaterials and Their Application to Wound Healing: A Review.
Chronic wounds are associated with considerable patient morbidity and present a significant economic burden to the healthcare system. Often, chronic wounds are in a state of persistent inflammation and unable to progress to the next phase of wound healing. Placental-derived biomaterials are recognized for their biocompatibility, biodegradability, angiogenic, anti-inflammatory, antimicrobial, antifibrotic, immunomodulatory, and immune privileged properties. As such, placental-derived biomaterials have been used in wound management for more than a century. Placental-derived scaffolds are composed of extracellular matrix (ECM) that can mimic the native tissue, creating a reparative environment to promote ECM remodeling, cell migration, proliferation, and differentiation. Reliable evidence exists throughout the literature to support the safety and effectiveness of placental-derived biomaterials in wound healing. However, differences in source (i.e., anatomical regions of the placenta), preservation techniques, decellularization status, design, and clinical application have not been fully evaluated. This review provides an overview of wound healing and placental-derived biomaterials, summarizes the clinical results of placental-derived scaffolds in wound healing, and suggests directions for future work.
Published In/Presented At
Protzman, N. M., Mao, Y., Long, D., Sivalenka, R., Gosiewska, A., Hariri, R. J., & Brigido, S. A. (2023). Placental-Derived Biomaterials and Their Application to Wound Healing: A Review. Bioengineering (Basel, Switzerland), 10(7), 829. https://doi.org/10.3390/bioengineering10070829
Medicine and Health Sciences
Department of Surgery